Surgical risk in patients with metabolic syndrome: Focus on lipids and hypertension

Current Cardiology Reports

Volumn 8, Issue 6, 2006, Pages 433-438

  Watson, Karol ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DISEASE PREDISPOSITION; DISORDERS OF CARBOHYDRATE METABOLISM; DYSLIPIDEMIA; GLUCOSE METABOLISM; HEART INFARCTION; HORMONAL REGULATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOMES RESEARCH; PERIOPERATIVE PERIOD; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SIGNAL TRANSDUCTION; SURGICAL PATIENT; SURGICAL RISK; VASCULITIS;

CARDIOVASCULAR DISEASES; HUMANS; METABOLIC SYNDROME X; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE;

EID: 33751046381     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-006-0101-3     Document Type: Review

References (44)

1. Heart Disease and Stroke Statistics - 2005 Update. Dallas: American Heart Association; 2005.
2. Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002, 288:1723-1727.
3. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996, 334:374-381.
4. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
5. Grundy SM, Brewer HB Jr, Cleeman JI, et al.: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/ American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438.
6. Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004, 27.-2444-2449.
7. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. WHO/NCD/NCS/99.2. Geneva: World Health Organization; 1999.
8. The IDF consensus worldwide definition of metabolic syndrome. International Diabetes Federation. Available at: http://www.idf.org/ webdata/docs/IDF_Metasyndrome_definition.pdf. Accessed November 3, 2005.
9. Lee YH, Pratley RE: The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 2005, 5:70-75.
10. Efraim R, Alpert MA: Definition of the metabolic syndrome: current proposals and controversies. Am J Med Sci 2005, 330:269-272.
11. Gal J, Bogar L, Acsady G, Kertai MD: Cardiac risk reduction in non-cardiac surgery: the role of anaesthesia and monitoring techniques. Eur J Anaesthesiol 2006, 23:641-648.
12. Jain NB, GuIler U, Pietrobon R, et al.: Comorbidities increase complication rates in patients having arthroplasty. Clin Orthop Relat Res 2005, 435:232-238.
13. Chobanian AV, Bakris GL, Black HR, et al.: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
14. Engeli S, Schling P, Gorzelniak K, et al.: The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 2003, 35:807-825.
15. Allman KG, Muir A, Howell SJ, et al.: Resistant hypertension and preoperative silent myocardial ischaemia in surgical patients. Br J Anaesth. 1994, 73:574-578.
16. The prevention or delay of type 2 diabetes. Diabetes Care 2002, 25:742-749.
17. Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
18. Lindstrom J, Eriksson JG, Valle TT, et al.: Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish diabetes prevention study: results from a randomized clinical trial. J Am Soc Nephrol 2003, 14(7 Suppl 2):SI08-S113.
19. Smiley DD, Umpierrez GE: Perioperative glucose control in the diabetic or nondiabetic patient. South Med J 2006, 99:580-589.
20. McGirt MJ, Woodworth GF, Brooke BS, et al.: Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy. Neurosurgery 2006, 58:1066-1073.
21. Krinsley J: Perioperative glucose control. Curr Opin Anaesthesiol 2006, 19:111-116.
22. Olefsky JM, Farquhar JW, Reaven GM: Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 1974, 57.551-560.
23. Sparks JE, Sparks CE: Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochem Biophys Acta 1994, 1215:9-32.
24. Lewis GF, Uffelman KD, Szeto LW, Steiner G: Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apo B production in normal weight and obese individuals. Diabetes 1993, 42:833-942.
25. Sparks JD, Sparks CE: Obese Zucker (fa/fa) rats are resistant to insulin's inhibitory effect on hepatic apo B secretion. Biochem Biopyhs Res Commun 1994, 205:417-422.
26. Aufenanger J, Walter H, Kattermann R: Studies of lipid and lipoprotein metabolism in man after surgical interventions. Langenbecks Arch Chir 1993, 378:41-48.
27. Bersot T, Haffner S, Harris WS, et al.: Hypertriglyceridemia: management of atherogenic dyslipidemia. J Fam Pract 2006, 55:S1-S8.
28. Mofidi R, Duff MD, Wigmore SJ, et al.: Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg 2006, 93:738-744.
29. Nasraway SA Jr, Albert M, Donnelly AM, et al.: Morbid obesity is an independent determinant of death among surgical critically ill patients. Crit Care Med 2006, 34:964-970.
30. Canturk Z, Canturk NZ, Cetinarslan B, et al.: Nosocomial infections and obesity in surgical patients. Obesity Res 2003, 11:769-775.
31. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89:2548-2556.
32. Stone JG, Foex P, Sear JW, et al.: Risk of myocardial ischaemia during anaesthesia in treated and untreated hypertensive patients. Br J Anaesth 1988, 61:675-679.
33. Wallace A, Layug B, Tateo I, et al.: Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998, 88:7-17.
34. Beckman JA, Brown KA, Calkins H, et al.: ACC/AHA 2006 guideline update for perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperatie beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2006, 47:2343-2355.
35. Palda VA, Detsky AS: Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 1997, 127-313-328.
36. Grayburn PA, Hillis LD: Cardiac events in patients undergoing noncardiac surgery: shifting the paradigm from noninvasive risk stratification to therapy. Ann Intern Med 2003, 138:506-511.
37. Butterworth J, Furberg CD: Improving cardiac outcomes after noncardiac surgery. Anesth Analg 2003, 97:613-615.
38. Paoletti R, Bolego C, Cignarella A: Lipid and non-lipid effects of statins. Handb Exp Pharmacol 2005, 170:365-388.
39. Lindenauer PK, Pekow P, Wang K, et al.: Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 2004, 291:2092-2099.
40. Poldermans D, Bax JJ, Kertai MD, et al.: Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003, 107:1848-1851.
41. O'Neil-Callahan K, Katsimaglis G, Tepper MR, et al.: Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 2005, 45:336-342.
42. Durazzo AE, Machado FS, Ikeoka DT, et al.: Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004, 39:967-975.
43. Kertai MD, Boersma E, Westerhout CM, et al.: A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 2004, 28:343-352.
44. Hoogwerf BJ: Perioperative management of diabetes mellitus: how should we act on the limited evidence? Cleve Clin J Med 2006, 73(Suppl 1):S95-S99.